This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lockwood, G. M. Articles by Ledger, W. L. Search for Related Content PubMed PubMed Citation Articles by Lockwood, G. M. Articles by Ledger, W. L.

Mid-Follicular Phase Pulses of Inhibin B Are Absent in Polycystic Ovarian Syndrome and Are Initiated by Successful Laparoscopic Ovarian Diathermy: A Possible Mechanism Regulating Emergence of the Dominant Follicle

Nuffield Department of Obstetrics and Gynaecology, Oxford Radcliffe Hospital (G.M.L., S.M., W.L.L.), Oxford; Diabetes Research Laboratories, Radcliffe Infirmary (D.R.M.), Oxford; School of Biological and Molecular Sciences, Oxford Brookes University, Oxford (N.P.G.)

Address all correspondence and requests for reprints to: Gillian M. Lockwood, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Maternity Department, Headington, Oxford, United Kingdom OX3 9DU.

The hypothalamic pulse generator of GnRH is recognized to be central to ovulatory function as evidenced by the anovulation of women with hypogonadotrophic hypogonadism due to Kallmann’s syndrome or severe anorexia nervosa. LH is released from the anterior pituitary in pulses, the frequency of which is closely entrained with those of GnRH. In contrast, secretion of FSH is influenced by a number of regulatory molecules, including GnRH, estradiol, inhibin, and activin. The close temporal relationship between changes in levels of inhibin B and FSH in the mid-follicular phase suggests that the release of inhibin B by the preovulatory follicle critically regulates pituitary FSH secretion. Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders affecting ovulation, and abnormal ovarian morphology as detected by ultrasonography remains the most sensitive diagnostic marker for this disorder. The etiology of PCOS is unclear, but its effective treatment by both anti-estrogens and by exogenous FSH suggests that a primary disorder of FSH regulation may be central. To investigate the possible role of inhibin B in the pathology of PCOS, serum inhibin B levels were measured in 10 women with PCOS on cycle day 5 of a spontaneous or progestrogen-provoked bleed and compared with levels on cycle day 5 of 10 women with regular ovulatory cycles. The mean serum inhibin B levels in the PCOS patients were significantly higher at 248 (±43.4) pg/mL compared with normal controls, 126 (±18.6) pg/mL (P < 0.01). Ten women with clomiphene resistant PCOS and 5 normal controls consented to undergo serial blood sampling on cycle day 5. Time Series Analysis using a Fourier Transformation to analyze the power spectrum of the data revealed that in normal women there is a distinct periodicity in inhibin B levels with a clear peak detectable every 60–70 min (P < 0.05), whereas in women with ovulatory dysfunction due to PCOS, no such pattern of regular pulsatility was seen. Four women with PCOS whose anovulation was successfully treated with laparoscopic ovarian diathermy (LOD) underwent repeat venous sampling following LOD. Their serum inhibin B levels fell to the upper limit of the normal range (160± 38.5) pg/mL, and pulsatility was initiated It is possible that inhibin B pulses are being generated directly by the ovary in response to pulses of GnRH in the peripheral circulation, or indirectly in response to FSH pulses arising in the pituitary. The function of inhibin B pulses in the mid-follicular phase of the normal cycle remains to be elucidated, but the absence of the normal pulsatile pattern in women with PCOS, in conjunction with high basal levels of inhibin B arising from the multiple small follicles characteristic of the PCOS ovary, appears to reinforce the development of a large cohort of small, developmentally arrested, and ultimately atretic follicles in these patients. Initiation of normal inhibin B pulsatility by LOD in patients with polycystic ovaries appears to correlate with the post-operative onset of ovular cycles.

This article has been cited by other articles:

				M. R. Sowers, A. D. Eyvazzadeh, D. McConnell, M. Yosef, M. L. Jannausch, D. Zhang, S. Harlow, and J. F. Randolph Jr. Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3478 - 3483. [Abstract] [Full Text] [PDF]

				A. Tsigkou, S. Marzotti, L. Borges, A. Brozzetti, F. Reis, P. Candeloro, M. Luisa Bacosi, V. Bini, F. Petraglia, and A. Falorni High Serum Inhibin Concentration Discriminates Autoimmune Oophoritis from Other Forms of Primary Ovarian Insufficiency J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1263 - 1269. [Abstract] [Full Text] [PDF]

				L. J. Moran, M. Noakes, P. M. Clifton, and R. J. Norman The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3796 - 3802. [Abstract] [Full Text] [PDF]

				S.A. Amer, W.L. Ledger, and T.C. Li Reply: Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 2073 - 2074. [Full Text] [PDF]

				M.L. Hendriks and C.B. Lambalk Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 2073 - 2073. [Full Text] [PDF]

				M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264. [Abstract] [Full Text] [PDF]

				S.A. Amer, S. Laird, W.L. Ledger, and T.C. Li Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome Hum. Reprod., February 1, 2007; 22(2): 389 - 394. [Abstract] [Full Text] [PDF]

				R. F. Casper and M. F. M. Mitwally Aromatase Inhibitors for Ovulation Induction J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 760 - 771. [Abstract] [Full Text] [PDF]

				S. Luisi, P. Florio, F. M. Reis, and F. Petraglia Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135. [Abstract] [Full Text] [PDF]

				K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]

				D. Nikolaou and C. Gilling-Smith Early ovarian ageing: are women with polycystic ovaries protected? Hum. Reprod., October 1, 2004; 19(10): 2175 - 2179. [Abstract] [Full Text] [PDF]

				M. F. M. Mitwally and R. F. Casper Aromatase Inhibition Reduces the Dose of Gonadotropin Required for Controlled Ovarian Hyperstimulation Reproductive Sciences, September 1, 2004; 11(6): 406 - 415. [Abstract] [PDF]

				C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, R. W. Naeraa, A.-M. Andersson, J. S. Christiansen, and N. E. Skakkebaek Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty Hum. Reprod., August 1, 2002; 17(8): 2049 - 2053. [Abstract] [Full Text] [PDF]

				J. S.E. Laven, B. Imani, M. J.C. Eijkemans, F. H. de Jong, and B. C.J.M. Fauser Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility Hum. Reprod., July 1, 2001; 16(7): 1359 - 1364. [Abstract] [Full Text] [PDF]

				R. J. Norman, C. R. Milner, N. P. Groome, and D. M. Robertson Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome Hum. Reprod., April 1, 2001; 16(4): 668 - 672. [Abstract] [Full Text] [PDF]

				C. K. Welt and A. L. Schneyer Differential Regulation of Inhibin B and Inhibin A by Follicle-Stimulating Hormone and Local Growth Factors in Human Granulosa Cells from Small Antral Follicles J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 330 - 336. [Abstract] [Full Text]

				M. W. Elting, T. J.M. Korsen, L. T.M. Rekers-Mombarg, and J. Schoemaker Women with polycystic ovary syndrome gain regular menstrual cycles when ageing Hum. Reprod., January 1, 2000; 15(1): 24 - 28. [Abstract] [Full Text] [PDF]

				H.M. Buckler, W.R. Robertson, A. Anderson, M. Vickers, and A. Lambert Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon) Hum. Reprod., December 1, 1999; 14(12): 2969 - 2973. [Abstract] [Full Text] [PDF]

				H. M. Fraser, N. P. Groome, and A. S. McNeilly Follicle-Stimulating Hormone-Inhibin B Interactions during the Follicular Phase of the Primate Menstrual Cycle Revealed by Gonadotropin-Releasing Hormone Antagonist and Antiestrogen Treatment J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1365 - 1369. [Abstract] [Full Text]